WAA has invited three (3) companies from the Alumni Start-Up Challenge earlier this month in New York City.
Each of the below companies will be allotted 30 mins for their pitch and Member Q&A. The last 30 minutes of this event will be a members only discussion of the presentations.
Here are the companies that will be presenting to WAA Members on 27-July. They have been invited to create a profile on Dealum. In the meanwhile, click on their company logo to visit their website::
(A Wharton Alumni Angels Portfolio Company) Develop the Next Generation of Stents. Fluid Biomed is commercializing the first polymer-based brain stent to cure aneurysms. Brain aneurysms afflict up to 5% of people and can lead to devastating stroke. Uniquely constructed of dissolving polymer and metal, this innovative medical device provides a scaffold to allow better healing and visualization of blood vessels.
Wearable neurotechnology that augments sleep, attention, and ultimately the human experience.
Unlocking lesion-level insights on drug efficacy. Every tumor matters in curing cancer. Vysioneer's mission is to help cancer patients receive the right treatment at the right moment.
This is a video event for WAA Members only.
Please register below in advance of this meeting.
----------
Wharton Alumni Angels is not a venture fund, an investment bank, a broker/dealer, investment clearing‐house, or an investment advisor. Wharton Alumni Angels is not registered with the U.S. Securities Exchange Commission or any other state’s or nation’s securities commission. For tax, compliance, reporting, legal or other requirements, it is highly recommended that members seek appropriate professional help. No representation or warranty is made as to the accuracy or completeness of the information provided by Wharton Alumni Angels or companies presenting investment opportunities. Wharton Alumni Angels presumes that any offering conducted by companies is a private placement and does not involve a public solicitation of investment.